Inventor · disambiguated record
Kevin Kozak
Also filed as: KOZAK KEVIN · KOZAK KEVIN R
9 granted patents·2 pending applications·42 citations·filing 2001–2019
85Inventor score
Top patents by PatentIndex Score
11 records- 0194US9480754B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2016·Granted Nov 1, 2016·11 cites·3 claims
- 0294US9345718B1Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2015·Granted May 24, 2016·12 cites·2 claims
- 0389US9925269B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2015·Granted Mar 27, 2018·4 cites·9 claims
- 0483US9925283B2Alkylphosphocholine analogs for multiple myeloma imaging and therapyWISCONSIN ALUMNI RES FOUND·Filed 2016·Granted Mar 27, 2018·4 cites·20 claims
- 0573US7189504B2Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolitesUNIV VANDERBILT·Filed 2001·Granted Mar 13, 2007·9 cites·37 claims
- 0670US7628975B2Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylgycerol metabolitesUNIV VANDERBILT·Filed 2005·Granted Dec 8, 2009·2 cites·21 claims
- 0767US11439709B2Phospholipid ether analogs as cancer-targeting drug vehiclesCELLECTAR BIOSCIENCES INC·Filed 2018·Granted Sep 13, 2022·0 cites·11 claims
- 0849US11467159B2Luminescent phospholipid analogs for the identification and isolation of circulating tumor cellsCELLECTAR BIOSCIENCES INC·Filed 2017·Granted Oct 11, 2022·0 cites·8 claims
- 0948US2020014642A1Enhanced Customer Interaction Platform for EnterprisesOV LOOP INC·Filed 2019·Application pending·0 cites
- 1042US7314709B2Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolismUNIV VANDERBILT·Filed 2002·Granted Jan 1, 2008·0 cites·10 claims
- 1139US2018153849A1Multi-drug combinations that act as potent radiosensitizersWISCONSIN ALUMNI RES FOUND·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →